NX PharmaGen
NX PharmaGen acquires, develops, and monetizes mature clinical-stage breakthrough technologies.
Launch date
Employees
Market cap
-
Enterprise valuation
$7—11m (Dealroom.co estimates Mar 2015.)
Louisville Kentucky (HQ)
Authorizing premium user...